Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GCA Korea
South Korea
- Ownership
- Private
- Development stage
- Other
01
Overview
GCA Korea is a South Korea-based testing, certification, and regulatory consulting company rather than a drug developer. The company helps global manufacturers enter the Korean market by providing one-stop support spanning import/customs assistance, product testing, certification, and post-approval follow-up. Its service scope includes KC certification for consumer and industrial products as well as MFDS regulatory support for medical devices and in vitro diagnostics. For healthcare customers, GCA Korea appears to operate primarily as a regulatory and market-access service provider focused on Korean compliance requirements, not as a therapeutics company with an internal clinical pipeline.
- Industry
- Consulting
Beyond the preview
Go deeper on GCA Korea.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on GCA Korea.